ET Solar Group Announces RMB400 Million Syndicate LoanNANJING, China, November 23 - ET Solar Group Corp. ("ET Solar"), a Nanjing-based photovoltaic ("PV") WinBuyer Closes US$6.9 Million in Series A Investment Led by Pitango Venture Capital, Joined by Giza Venture CapitalTEL AVIV, Israel, November 23 - WinBuyer, the leader in the growing market for Onsite Comparative Pricing First Mutual Fund Investment in Microfinance in IndiaCHENNAI, India, November 20 - A recent micro-loan securitisation, completed by IFMR Capital and Equitas Manthan Systems Secures Series B Financing From Fidelity International, IDG Ventures and DFJ ePlanet VenturesManthan Plans to Use Funding to Target Leadership Position in Retail Business Intelligence & Analytics Balda AG Reduces Stake in TPKBalda AG Sells up to 18.75 Percent of its Shareholding in Touch Screen Producer TPK Aleris Europe Announces Price Increase for Aluminium Coil and Sheet ProductsNEUHAUSEN AM RHEINFALL, Switzerland, November 16 - Aleris Europe announced today a price increase of 50 Euros per ton for Cash4Gold.Com Sponsors Aaron Riley Versus Ross Pearson in Highly Anticipated Fight and Sees Growing Excitement in Britain Around Online Gold-Buying Services and Mixed Martial Arts (MMA)LONDON, November 13 - Cash4Gold.com (www.cash4gold.com/), the world's #1 gold buyer Apprenda Closes US$5 Million Investment Led by New Enterprise AssociatesALBANY, New York - - Company’s SaaSGrid Speeds On-Demand Software to Market for Customers Sirius Genomics received NRC-IRAP Funding for Continued Development of a Sepsis Companion DiagnosticVANCOUVER - Sirius Genomics, a developer of pharmacogenomic diagnostics, announced today that it has signed its first Contribution Agreement with the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP). This research funding will be used to study genomic correlations in severe sepsis patients. Specifically, the contribution will go towards the continued development of Sirius’ pharmacogenomic diagnostic intended to assess responsiveness to recombinant human activated Protein C (developed and marketed by Eli Lilly and Company under the trademark Xigris (R)) in patients with severe sepsis at high risk of death. Varicent Software Secures US$35 Million in Funding to Further Accelerate GrowthTORONTO - - Company secures second-largest IT funding deal in Q3 2009 Varicent Software Incorporated, a leading innovator and provider of sales performance management (SPM) and incentive compensation management (ICM) solutions today announced it has raised US$35 million in additional funding led by San Francisco and New York-based FTV Capital. RBC Venture Partners and EdgeStone Capital Partners, current investors in Varicent, also participated in the new round of funding. Largest British Fund for Biomedical Research Finances Project on Breakbone Fever in Leuven (K.U.Leuven)LEUVEN, Belgium - - The Laboratory for Virology and Experimental Chemotherapy (Rega Institute) and the “Centre for Drug Design and Discovery” (CD3) at K.U.Leuven will receive a total of 2.8 million euro from the British Wellcome Trust. - They will apply these funds to the search for possible new medication for the treatment of infections related to the ‘dengue fever virus’. Dengue or ‘breakbone fever’ is widespread in tropical and subtropical regions. As of yet, there is neither a vaccine nor any form of treatment for this disease. - The findings of the researchers in Leuven will be developed further into medication, in co-operation with the pharmaceutical industry. - The Wellcome Trust is the largest independent fund for biomedical research in the United Kingdom. This is the first time that the fund is financing technology transfer on the European continent. ION and BGP Announce Joint Venture for Land Seismic EquipmentHOUSTON and BEIJING - - ION to Receive US$175 Million Capital Infusion from BGP Majority of ION Debt to be Repaid or Refinanced at Closing Joseph F. Finn, Jr., Assignee for the Benefit of Creditors of EPIX Pharmaceuticals, Inc., Releases Statement Regarding Liquidation ProcessWELLESLEY HILLS, Massachusetts - The previously announced auction of assets of EPIX Pharmaceuticals, Inc. was conducted on October 21, 2009. As of today, claims filed against the estate far exceed the assets available for distribution to creditors. The Assignee will continue to liquidate assets and review the claims filed against the estate, but at this juncture, it does not appear that creditors will be paid in full or that there will be any assets available for distribution to shareholders of EPIX Pharmaceuticals. Volta Closes CDN$8,314,045 Bought Deal Private PlacementTORONTO - Volta Resources Inc. (”Volta” or the “Company”) (TSX:VTR) announces that the Company has closed its previously announced “bought deal” private placement entered into with a syndicate of underwriters (the “Underwriters”), led by Wellington West Capital Markets Inc. and includes Cormark Securities Inc., M Partners Inc. and Dundee Securities Corporation, pursuant to which the Underwriters have purchased, or found substitute purchasers to purchase from Volta, 15,200,000 subscription receipts (”Sub Receipts”) at a price of CDN $0.33 per Sub Receipt for gross proceeds of CDN $5,016,000 (the “Offering”). The Underwriters also exercised their option to purchase an additional 9,994,075 Sub Receipts for additional gross proceeds of CDN $3,298,045. Biocartis Raises EUR10 Million in Series A Financing RoundLAUSANNE, Switzerland - Biocartis SA, a diagnostics company focused on fast and low-cost, integrated molecular and immunodiagnostics based on its proprietary micro-technology platform, today announced the successful closing of a Series A equity financing round. The Company raised EUR 10 million (~ USD 14.9 million) from a syndicate of leading life science investors. Crescendo Biologics Raises GBP4.5 million in Seed-Funding Led by Sofinnova PartnersCAMBRIDGE, England - Crescendo Biologics (”Crescendo”) today announces it has raised GBP4.5 million in a seed-funding round to advance the development of its fragment antibody technology platforms. The funding round was led by Sofinnova Partners, a Paris-based venture capital firm, with Aitua, Avlar BioVentures and the Rainbow Seed Fund also participating. BMEYE B.V. Completes EUR 6 Million Series B Financing RoundAMSTERDAM - - New Investors Earlybird and 360 Capital Partners led the Round BMEYE B.V., the non-invasive cardiovascular monitoring company, today announced the successful completion of its Series B financing round, raising EUR 6 million. New investors Earlybird, who led this round, and 360 Capital Partners participated in the financing, along with other existing BMEYE shareholders as LSP (Life Sciences Partners) and Techfund. Assist America Sponsors the Bedouin Heritage ProjectPRINCETON, New Jersey - Assist America, Princeton, N.J., U.S.A., is pleased to announce its sponsorship of the Bedouin Heritage Project, an organization dedicated to safeguarding and preserving the lifestyle, oral traditions and culture of the Bedu in the Wadi Rum region of Jordan. As a supporter, Assist America has funded a 2-year scholarship for a student without financial means to participate in the Project’s endeavors, and is also providing complimentary global emergency services for all active individuals working for the organization for the same timeframe. Neopharma Expands Into Biotechnology and Nanotechnology-Based Research and DevelopmentDUBAI, UAE - Neopharma, the Abu Dhabi-based pharmaceuticals manufacturer, has ventured into biotechnology and nanotechnology-based research and manufacturing capabilities. Bicycle Therapeutics Ltd, a New Medical Research Council (MRC) Spin-out, Seeking to Merge Best Aspects of Small Molecules and Biologics, Secures Seed Funding From Top Venture Capital FirmsLONDON - Bicycle Therapeutics Ltd, a new biotechnology company developing a novel technology platform for the creation of a new generation of biotherapeutics, has secured seed funding from Atlas Venture and Novartis Venture Fund. Accumetrics Announces US$16.5M in New Capital FinancingSAN DIEGO - - Despite Difficult Markets, Cutting-Edge Medical Diagnostics Company Oversubscribes Its Fundraising Effort ContourGlobal and OPIC Sign Agreement to Partner in Energy ProjectsNEW YORK - ContourGlobal and The Overseas Private Investment Corporation (OPIC) announced today an agreement whereby the two organizations will partner in supporting power projects in emerging markets, including ‘tri-generation’ and ‘quad-generation’ facilities which help to reduce carbon dioxide emissions. Oil Refineries 50%-Held Carmel Olefins Publishes Update on Financial CovenantsHAIFA, Israel - Oil Refineries Ltd. (TASE: ORL.TA) (”ORL”),Israel’s largest oil refiner, announced that Carmel Olefins Ltd. (”CAOL”), in which ORL holds 50% of the capital, published an immediate report with regards to its entering into a Series of Agreements with regards to eased financial terms. Please find following a convenience translation from Hebrew of CAOL’s formal announcement to the Tel Aviv Stock Exchange and Israel Securities Authority from Thursday, October 1, 2009. Dubai Group Statement in Response to Announcement by Bank Islam Malaysia BerhadDUBAI, United Arab Emirates - “Following an earlier announcement by BIMB Holdings Berhad BHB (”Bank Islam”) with regards to its April 2009 offer for the capital increase, Dubai Group confirms that it is in the process of reviewing its strategic options relating to its stake. Bank Islam boasts strong attributes across the Asian banking sector, and the capital raise offer came in reflection of the successful transformation plan implemented by Bank Islam since 2006. However, following the reassessment of its investment strategy, Dubai Group has redirected its competitive advantage closer to home, namely the GCC and greater Middle East regions. Malaysia does remain a key market for future investments.” Stream Global Services, Inc. Announces Close of Stock-for-Stock Transaction With eTelecare Global Solutions and Close of Financing Transactions of Approximately US$300 MillionBOSTON - - Creates a Global BPO Services Company Approaching US$1 Billion in Projected Revenue in 2010 and Approximately 30,000 Combined Employees Silver Wheaton Completes US$287.5 Million FinancingVANCOUVER - Silver Wheaton Corp. (”Silver Wheaton” or the “Company”) (TSX, NYSE:SLW) is pleased to confirm that it has closed its previously announced bought deal equity financing, including the full amount of the underwriters’ over- allotment option, for aggregate gross proceeds to Silver Wheaton of US$287.5 million. A syndicate of underwriters, led by Genuity Capital Markets and GMP Securities L.P., and including BMO Nesbitt Burns Inc., Scotia Capital Inc., Canaccord Capital Corporation, UBS Securities Canada Inc., Blackmont Capital Inc., HSBC Securities (Canada) Inc., Macquarie Capital Markets Canada Ltd., Merrill Lynch Canada Inc., Raymond James Ltd., RBC Dominion Securities Inc., Salman Partners Inc. and CIBC World Markets Inc., purchased an aggregate of 25,903,750 common shares of Silver Wheaton at a price of US$11.10 per share. Elsevier Launches SciVal Funding Solution to Help U.S. Research Institutions Better Compete for GrantsAMSTERDAM - - Optimizes Grant Seeking Process by Integrating Current Funding Opportunities with Historical Award Information and Publication Data Noront Resources and Marten Falls First Nation Enter Negotiations for Exploration Agreement and PartnershipsTORONTO - Symbol: NOT:TSX-V Shares Outstanding: 163,631,957 Fully Diluted: 173,461,957 Emerging Capital Partners Invests in East African Media and Telecommunications CompanyWASHINGTON - - ECP Shows Commitment to African Telecom with Investment in Wananchi, Firm’s 10th in Sector ProLogis Closes Two Financings for ProLogis European Properties Fund IIDENVER - - Proceeds Used to Pay Down Warehouse Line - ProLogis (NYSE: PLD), a leading global provider of distribution facilities, announced today it has completed two financings, for a total of approximately euro 133 million, on behalf of ProLogis European Properties Fund II (PEPF II). Proceeds from the financings were used to pay down PEPF II’s warehouse line of credit. Agendia Raises US $23 Million in Series E FinancingHUNTINGTON BEACH, California and AMSTERDAM - - Company to Present at UBS Global Life Sciences Conference on Sept. 23 Mortgage Refinance - 7 Things That You Need Know About“Mortgage refinancing – doubts and myths explained.” Refinancing a mortgage is just like availing your first mortgage, but with some variations - Refinanceitt.com. GSMA Announces Details of Initial Grants Awarded Through the Mobile Money for the Unbanked ProgrammeLONDON - - GSMA Closer to Goal of Creating Financial Security for 20m Unbanked by 2012 Nova Scotia Business Inc. - LED Roadway Lighting Has Bright FutureAMHERST, Canada - A home-grown Nova Scotia company continues to shine brightly with its LED-based street lighting fixtures. Business Monitor International Announces Substantial Investment by Spectrum Equity InvestorsLONDON - Business Monitor International Limited (”BMI”), a leading global provider of country risk analysis, macroeconomic forecasting and industry research, announced today that it has received a substantial, non-controlling equity investment from Spectrum Equity Investors. The investment will accelerate the expansion of BMI’s portfolio of services, and position the company to execute on its global expansion strategy. Following the transaction, Chris Mitchell and Adam Margolin from Spectrum will join the BMI board of directors. Terms of the transaction were not disclosed. |